MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06773cam a2200733Ii 4500 |
| 001 - |
|---|
| control field |
ocn945658059 |
| 003 - |
|---|
| control field |
OCoLC |
| 005 - |
|---|
| control field |
20190719103222.0 |
| 006 - |
|---|
| fixed length control field |
m o d |
| 007 - |
|---|
| fixed length control field |
cr cnu---unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
160329s2016 enk ob 001 0 eng d |
| 040 ## - |
|---|
| -- |
OPELS |
| -- |
eng |
| -- |
rda |
| -- |
pn |
| -- |
OPELS |
| -- |
N$T |
| -- |
YDXCP |
| -- |
EBLCP |
| -- |
IDEBK |
| -- |
OCLCF |
| -- |
CDX |
| -- |
DEBSZ |
| -- |
OCLCQ |
| -- |
U3W |
| -- |
D6H |
| -- |
WYU |
| 019 ## - |
|---|
| -- |
945641459 |
| -- |
945752315 |
| -- |
946310361 |
| -- |
1066624168 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323428866 |
| Qualifying information |
electronic bk. |
|
|---|
| International Standard Book Number |
032342886X |
| Qualifying information |
electronic bk. |
|
|---|
| -- |
9780323428637 |
|
|---|
| -- |
0323428630 |
| 035 ## - |
|---|
| -- |
(OCoLC)945658059 |
| -- |
(OCoLC)945641459 |
| -- |
(OCoLC)945752315 |
| -- |
(OCoLC)946310361 |
| -- |
(OCoLC)1066624168 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| -- |
R857.N34 |
| 072 #7 - |
|---|
| -- |
HEA |
| -- |
012000 |
| -- |
bisacsh |
|
|---|
| -- |
HEA |
| -- |
020000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
004000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
101000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
109000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
029000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
040000 |
| -- |
bisacsh |
|
|---|
| -- |
MED |
| -- |
092000 |
| -- |
bisacsh |
| 082 04 - |
|---|
| Classification number |
610.28 |
| -- |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Nanobiomaterials in cancer therapy : |
| Remainder of title |
applications of nanobiomaterials / |
| Statement of responsibility, etc |
edited by Alexandru Mihai Grumezescu. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource |
| 505 0# - |
|---|
| Formatted contents note |
Front Cover; Nanobiomaterials in Cancer Therapy; Copyright Page; Contents; List of contributors; Preface of the series; Preface; About the Series (Volumes I-XI); About Volume VII; 1 Nanopreparations for skin cancer therapy; 1.1 Introduction; 1.2 Skin Morphology; 1.3 Types of Cancer; 1.4 Non-Melanoma Skin Cancer; 1.5 Melanoma Skin Cancer; 1.6 Penetration Pathways of Skin; 1.7 Drug Delivery Systems Applied to Skin Cancer Treatment; 1.8 Liposomes; 1.9 Nanoemulsions and Nanosuspensions; 1.10 Polymeric Nanoparticles; 1.11 Lipid Nanoparticles; 1.12 Dendrimers; 1.13 Photodynamic Therapy |
|
|---|
| Formatted contents note |
1.14 ConclusionsReferences; 2 Silver nanoparticles in cancer therapy; 2.1 Introduction; 2.2 Silver Nanoparticles; 2.3 Synthesis; 2.3.1 Chemical Synthesis; 2.3.2 Physical Synthesis; 2.3.3 Biological Synthesis; 2.3.3.1 Silver nanoparticles synthesized by bacteria; 2.3.3.2 Silver nanoparticles synthesized by fungi; 2.3.3.3 Silver nanoparticles synthesized by plants; 2.4 Shape; 2.5 Silver Nanoparticles-Cancer Diagnosis and Treatment Applications; 2.5.1 Leukemia; 2.5.2 Breast Cancer; 2.5.3 Lung Cancer; 2.5.4 Prostate Cancer; 2.5.5 Hepatic Cancer; 2.5.6 Cervical Cancer; 2.5.7 Skin Cancer |
|
|---|
| Formatted contents note |
2.5.8 Larynx Cancer2.5.9 Colon Cancer; 2.6 Conclusions; References; 3 Nanobiomaterials in cancer therapy; 3.1 Introduction; 3.2 The Enhanced Permeability and Retention (EPR) Effect; 3.3 Nanomaterials in Cancer Therapy; 3.3.1 Inorganic NPs; 3.3.1.1 Quantum dots; 3.3.1.2 Magnetic NPs; 3.3.2 Organic NPs; 3.3.2.1 Liposomes; 3.3.2.2 Polymeric micelles; 3.3.2.3 Dendrimers; 3.4 Chemotherapy-Based Nanoformulations; 3.4.1 Doxorubicin; 3.4.2 Paclitaxel; 3.4.3 Cisplatin; 3.4.4 Docetaxel; 3.4.5 Nanotetrac; 3.5 Multifunctional NPs; 3.5.1 Delivery of siRNA and shRNA Complexes; 3.5.2 Active Targeting |
|
|---|
| Formatted contents note |
3.6 Cancer Therapy Using Natural Products: Nanochemoprevention3.6.1 EGCG; 3.6.2 Resveratrol; 3.6.3 Curcumin; 3.7 Cancer Stem Cells: A Nanotechnology Perspective; 3.8 Conclusions; References; 4 Advances in nanobiomaterials for oncology nanomedicine; 4.1 Introduction; 4.2 Organic Nanobiomaterials; 4.2.1 Liposomes; 4.2.2 Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC); 4.2.3 Polymeric Nanocapsules and Nanospheres; 4.3 Inorganic Nanobiomaterials; 4.3.1 Mesoporous Silica Nanoparticles (MSNs); 4.3.2 Spherical Nucleic Acid Nanoparticles (SNA-NPs) |
|
|---|
| Formatted contents note |
4.3.3 Boron Nitride Nanotubes (BNNTs)4.4 Combination of Nanotechnology with Photodynamic Therapy to Improve Cancer Treatment; 4.5 Toxicity and Risk Management; 4.6 Conclusions; Acknowledgments; References; 5 Nanobiomaterials: Emerging platform in cancer theranostics; 5.1 Introduction; 5.2 Theranostics and Nanomedicine; 5.2.1 Gold Nanoparticles; 5.2.2 Iron Oxide Nanoparticles in Cancer Theranostics; 5.2.3 Superparamagnetic Iron Oxide Nanoparticles; 5.2.4 Carbon Nanotubes; 5.2.5 Quantum Dots; 5.2.6 Dendrimers; 5.2.7 Vesicular Systems; 5.2.7.1 Liposomes; 5.2.7.2 Polymerosomes |
| 650 #0 - |
|---|
| Topical term or geographic name as entry element |
Nanomedicine. |
|
|---|
| Topical term or geographic name as entry element |
Cancer |
|
|---|
| Topical term or geographic name as entry element |
Nanobiotechnology. |
|
|---|
| Topical term or geographic name as entry element |
Biomedical materials. |
|
|---|
| Topical term or geographic name as entry element |
HEALTH & FITNESS / Holism |
|
|---|
| Topical term or geographic name as entry element |
HEALTH & FITNESS / Reference |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Alternative Medicine |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Atlases |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Essays |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Family & General Practice |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Holistic Medicine |
|
|---|
| Topical term or geographic name as entry element |
MEDICAL / Osteopathy |
|
|---|
| Topical term or geographic name as entry element |
Biomedical materials. |
|
|---|
| Topical term or geographic name as entry element |
Cancer |
|
|---|
| Topical term or geographic name as entry element |
Nanobiotechnology. |
|
|---|
| Topical term or geographic name as entry element |
Nanomedicine. |
| 700 1# - |
|---|
| Personal name |
Grumezescu, Alexandru Mihai, |
| Relator term |
editor. |
| 856 40 - |
|---|
| Uniform Resource Identifier |
http://www.sciencedirect.com/science/book/9780323428637 |
| 264 #1 - |
|---|
| -- |
Oxford : |
| -- |
William Andrew, an imprint of Elsevier, |
| -- |
2016. |
| 336 ## - |
|---|
| -- |
text |
| -- |
txt |
| -- |
rdacontent |
| 337 ## - |
|---|
| -- |
computer |
| -- |
c |
| -- |
rdamedia |
| 338 ## - |
|---|
| -- |
online resource |
| -- |
cr |
| -- |
rdacarrier |
| 588 0# - |
|---|
| -- |
Online resource; title from PDF title page (EBSCO, viewed March 31, 2016) |
| 520 ## - |
|---|
| -- |
Nanobiomaterials in Cancer Therapy presents the major applications of nanobiomaterials in oncology, offering an up-to-date overview of the latest research in this field. Utilizing nanobiomaterials, novel therapeutic approaches enable significant improvements in drug-loading capacity, formulation stability and drug efficiency. In this book, leading researchers from around the world share their expertise and unique insights. The book covers the fabrication methods of platforms for multimodal and combinatorial therapeutic options, along with simultaneous and real-time cancer imaging, and innovative approaches for oncology by passive or active pathways of multifunctional nanocarriers. The work also classifies and discusses engineered nanobiosystems for cancer therapy, prevention, and low cancer recurrence or relapse. This book will be of interest to postdoctoral researchers, professors and students engaged in the fields of materials science, biotechnology and applied chemistry. It will also be highly valuable to those working in industry, including pharmaceutics and biotechnology companies, medical researchers, biomedical engineers and advanced clinicians. |
| 504 ## - |
|---|
| -- |
Includes bibliographical references and index. |
|
|---|
| -- |
Treatment. |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
bisacsh |
|
|---|
| -- |
fast |
| -- |
(OCoLC)fst00832586 |
|
|---|
| -- |
Treatment. |
| -- |
fast |
| -- |
(OCoLC)fst00845538 |
|
|---|
| -- |
fast |
| -- |
(OCoLC)fst01894713 |
|
|---|
| -- |
fast |
| -- |
(OCoLC)fst01744350 |
| 655 #4 - |
|---|
| -- |
Electronic books. |
|
|---|
| -- |
Electronic books. |
| 776 08 - |
|---|
| -- |
Original |
| -- |
9780323428637 |
| -- |
0323428630 |
| -- |
(OCoLC)932174426 |
| 856 40 - |
|---|
| -- |
ScienceDirect |
